APO Research
Talk to an analyst

APO RESEARCH · REPORT

Conjugate Vaccine

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.

Selected research

Industry Growth & Trends

Global Conjugate Vaccine Industry Growth and Trends Forecast to 2032

26 December 202593 pages

Choose your research edition.

Industry ResearchConjugate Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Conjugate Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Conjugate Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Conjugate Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Conjugate Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.

Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Conjugate Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Conjugate Vaccine market size, estimates, and forecasts are presented in terms of sales volume (Million Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Conjugate Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Conjugate Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Conjugate Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Conjugate Vaccine Market by Company

Pfizer

GSK

Sanofi

Merck

Walvax Biotechnology

Royal (Wuxi) Bio-Pharmaceutical

Bharat Biotech

Zhifei Biologic

Conjugate Vaccine Segment by Type

Hib Vaccine

Meningococcal Vaccine

Pneumococcal Vaccine

Others

Conjugate Vaccine Segment by End Users

Children

Adult

Conjugate Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Conjugate Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Conjugate Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Conjugate Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Conjugate Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Conjugate Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hib Vaccine Table 2. Major Company of Meningococcal Vaccine Table 3. Major Company of Pneumococcal Vaccine Table 4. Major Company of Others Table 5. Global Conjugate Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit) Table 7. Global Conjugate Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Conjugate Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Conjugate Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Conjugate Vaccine Price by Type (2021-2026) & (USD/Unit) Table 11. Global Conjugate Vaccine Sales by Type (2027-2032) & (Million Unit) Table 12. Global Conjugate Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Conjugate Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Conjugate Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Conjugate Vaccine Price by Type (2027-2032) & (USD/Unit) Table 16. North America Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit) Table 17. North America Conjugate Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit) Table 19. Europe Conjugate Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit) Table 21. Asia-Pacific Conjugate Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit) Table 23. Latin America Conjugate Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Conjugate Vaccine Sales by Type (2021-2026) & (Million Unit) Table 25. Middle East and Africa Conjugate Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Conjugate Vaccine Industry Trends Table 27. Conjugate Vaccine Industry Drivers Table 28. Conjugate Vaccine Industry Opportunities and Challenges Table 29. Conjugate Vaccine Industry Restraints Table 30. Global Conjugate Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Conjugate Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Conjugate Vaccine Sales by Company (2021-2026) & (Million Unit) Table 33. Global Conjugate Vaccine Sales Share by Company (2021-2026) Table 34. Global Conjugate Vaccine Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Conjugate Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Conjugate Vaccine Major Company Production Sites and Headquarters Table 37. Global Conjugate Vaccine Company, Product Type & Application Table 38. Global Conjugate Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Conjugate Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Conjugate Vaccine Sales by Region (2021-2026) & (Million Unit) Table 43. Global Conjugate Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Conjugate Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Conjugate Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Conjugate Vaccine Sales (Million Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Conjugate Vaccine Sales by Region (2027-2032) & (Million Unit) Table 48. Global Conjugate Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Conjugate Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Conjugate Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Conjugate Vaccine Sales (Million Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Conjugate Vaccine Sales by End Users (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Conjugate Vaccine Sales by End Users (2021-2026) & (Million Unit) Table 54. Global Conjugate Vaccine Sales Market Share in Volume by End Users (2021-2026) Table 55. Global Conjugate Vaccine Sales by End Users (2021-2026) & (US$ Million) Table 56. Global Conjugate Vaccine Sales Market Share in Value by End Users (2021-2026) Table 57. Global Conjugate Vaccine Price by End Users (2021-2026) & (USD/Unit) Table 58. Global Conjugate Vaccine Sales by End Users (2027-2032) & (Million Unit) Table 59. Global Conjugate Vaccine Sales Market Share in Volume by End Users (2027-2032) Table 60. Global Conjugate Vaccine Sales by End Users (2027-2032) & (US$ Million) Table 61. Global Conjugate Vaccine Sales Market Share in Value by End Users (2027-2032) Table 62. Global Conjugate Vaccine Price by End Users (2027-2032) & (USD/Unit) Table 63. North America Conjugate Vaccine Sales by End Users (2021-2026) & (Million Unit) Table 64. North America Conjugate Vaccine Sales by End Users (2021-2026) & (US$ Million) Table 65. Europe Conjugate Vaccine Sales by End Users (2021-2026) & (Million Unit) Table 66. Europe Conjugate Vaccine Sales by End Users (2021-2026) & (US$ Million) Table 67. Asia-Pacific Conjugate Vaccine Sales by End Users (2021-2026) & (Million Unit) Table 68. Asia-Pacific Conjugate Vaccine Sales by End Users (2021-2026) & (US$ Million) Table 69. Latin America Conjugate Vaccine Sales by End Users (2021-2026) & (Million Unit) Table 70. Latin America Conjugate Vaccine Sales by End Users (2021-2026) & (US$ Million) Table 71. Middle East and Africa Conjugate Vaccine Sales by End Users (2021-2026) & (Million Unit) Table 72. Middle East and Africa Conjugate Vaccine Sales by End Users (2021-2026) & (US$ Million) Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Conjugate Vaccine Product Portfolio Table 77. Pfizer Recent Development Table 78. GSK Company Information Table 79. GSK Business Overview Table 80. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. GSK Conjugate Vaccine Product Portfolio Table 82. GSK Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Sanofi Conjugate Vaccine Product Portfolio Table 87. Sanofi Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Merck Conjugate Vaccine Product Portfolio Table 92. Merck Recent Development Table 93. Walvax Biotechnology Company Information Table 94. Walvax Biotechnology Business Overview Table 95. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Walvax Biotechnology Conjugate Vaccine Product Portfolio Table 97. Walvax Biotechnology Recent Development Table 98. Royal (Wuxi) Bio-Pharmaceutical Company Information Table 99. Royal (Wuxi) Bio-Pharmaceutical Business Overview Table 100. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio Table 102. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 103. Bharat Biotech Company Information Table 104. Bharat Biotech Business Overview Table 105. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Bharat Biotech Conjugate Vaccine Product Portfolio Table 107. Bharat Biotech Recent Development Table 108. Zhifei Biologic Company Information Table 109. Zhifei Biologic Business Overview Table 110. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Zhifei Biologic Conjugate Vaccine Product Portfolio Table 112. Zhifei Biologic Recent Development Table 113. North America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (Million Unit): 2021 VS 2025 VS 2032 Table 114. North America Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit) Table 115. North America Conjugate Vaccine Sales Market Share by Country (2021-2026) Table 116. North America Conjugate Vaccine Sales Forecast by Country (2027-2032) & (Million Unit) Table 117. North America Conjugate Vaccine Sales Market Share Forecast by Country (2027-2032) Table 118. North America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Conjugate Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Conjugate Vaccine Market Share by Country (2021-2026) Table 121. North America Conjugate Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Conjugate Vaccine Market Share Forecast by Country (2027-2032) Table 123. Europe Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (Million Unit): 2021 VS 2025 VS 2032 Table 124. Europe Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit) Table 125. Europe Conjugate Vaccine Sales Market Share by Country (2021-2026) Table 126. Europe Conjugate Vaccine Sales Forecast by Country (2027-2032) & (Million Unit) Table 127. Europe Conjugate Vaccine Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Conjugate Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Conjugate Vaccine Market Share by Country (2021-2026) Table 131. Europe Conjugate Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Conjugate Vaccine Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (Million Unit): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit) Table 135. Asia-Pacific Conjugate Vaccine Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Conjugate Vaccine Sales Forecast by Country (2027-2032) & (Million Unit) Table 137. Asia-Pacific Conjugate Vaccine Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Conjugate Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Conjugate Vaccine Market Share by Country (2021-2026) Table 141. Asia-Pacific Conjugate Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Conjugate Vaccine Market Share Forecast by Country (2027-2032) Table 143. Latin America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (Million Unit): 2021 VS 2025 VS 2032 Table 144. Latin America Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit) Table 145. Latin America Conjugate Vaccine Sales Market Share by Country (2021-2026) Table 146. Latin America Conjugate Vaccine Sales Forecast by Country (2027-2032) & (Million Unit) Table 147. Latin America Conjugate Vaccine Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Conjugate Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Conjugate Vaccine Market Share by Country (2021-2026) Table 151. Latin America Conjugate Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Conjugate Vaccine Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (Million Unit): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Conjugate Vaccine Sales by Country (2021-2026) & (Million Unit) Table 155. Middle East and Africa Conjugate Vaccine Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Conjugate Vaccine Sales Forecast by Country (2027-2032) & (Million Unit) Table 157. Middle East and Africa Conjugate Vaccine Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Conjugate Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Conjugate Vaccine Market Share by Country (2021-2026) Table 161. Middle East and Africa Conjugate Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Conjugate Vaccine Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Conjugate Vaccine Distributors List Table 166. Conjugate Vaccine Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Conjugate Vaccine Image Figure 2. Global Conjugate Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Conjugate Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Conjugate Vaccine Sales (2021-2032) & (Million Unit) Figure 5. Hib Vaccine Image Figure 6. Global Hib Vaccine Sales YoY Growth (2021-2032) & (Million Unit) Figure 7. Meningococcal Vaccine Image Figure 8. Global Meningococcal Vaccine Sales YoY Growth (2021-2032) & (Million Unit) Figure 9. Pneumococcal Vaccine Image Figure 10. Global Pneumococcal Vaccine Sales YoY Growth (2021-2032) & (Million Unit) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Million Unit) Figure 13. Global Conjugate Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Conjugate Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Conjugate Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Conjugate Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Conjugate Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Conjugate Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Conjugate Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Conjugate Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Conjugate Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Conjugate Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Conjugate Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Conjugate Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Conjugate Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (Million Unit) Figure 29. Adult Image Figure 30. Global Adult Sales YoY Growth (2021-2032) & (Million Unit) Figure 31. Global Conjugate Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Conjugate Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Conjugate Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Conjugate Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Conjugate Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Conjugate Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Conjugate Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Conjugate Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Conjugate Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Conjugate Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Conjugate Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Conjugate Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Conjugate Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Million Unit) Figure 44. North America Conjugate Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Conjugate Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Conjugate Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Conjugate Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Million Unit) Figure 48. Europe Conjugate Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Conjugate Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Conjugate Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Conjugate Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Million Unit) Figure 52. Asia-Pacific Conjugate Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Conjugate Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Conjugate Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Conjugate Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Million Unit) Figure 56. Latin America Conjugate Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Conjugate Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Conjugate Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Conjugate Vaccine Sales by Country: 2021 VS 2025 VS 2032 (Million Unit) Figure 60. Middle East and Africa Conjugate Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Conjugate Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Conjugate Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Conjugate Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Conjugate Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hib Vaccine
  • Meningococcal Vaccine
  • Pneumococcal Vaccine
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Pfizer
  • GSK
  • Sanofi
  • Merck
  • Walvax Biotechnology
  • Royal (Wuxi) Bio-Pharmaceutical
  • Bharat Biotech
  • Zhifei Biologic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Conjugate Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Conjugate Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Conjugate Vaccine Market by Type
  6. 1.3.1 Hib Vaccine
  7. 1.3.2 Meningococcal Vaccine
  8. 1.3.3 Pneumococcal Vaccine
  9. 1.3.4 Others
  10. 1.4 Global Conjugate Vaccine Market Size by Type
  11. 1.4.1 Global Conjugate Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Conjugate Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Conjugate Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Conjugate Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Conjugate Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Conjugate Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Conjugate Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Conjugate Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Conjugate Vaccine Industry Trends
  2. 2.2 Conjugate Vaccine Industry Drivers
  3. 2.3 Conjugate Vaccine Industry Opportunities and Challenges
  4. 2.4 Conjugate Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Conjugate Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Conjugate Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Conjugate Vaccine Price (2021-2026)
  4. 3.4 Global Conjugate Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Conjugate Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Conjugate Vaccine Company, Product Type & Application
  7. 3.7 Global Conjugate Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Conjugate Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Conjugate Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Conjugate Vaccine Tier 1, Tier 2, and Tier 3
4 Conjugate Vaccine Regional Status and Outlook
  1. 4.1 Global Conjugate Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Conjugate Vaccine Historic Market Size by Region
  3. 4.2.1 Global Conjugate Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Conjugate Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Conjugate Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Conjugate Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Conjugate Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Conjugate Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Conjugate Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Conjugate Vaccine by Application
  1. 5.1 Conjugate Vaccine Market by End Users
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Conjugate Vaccine Market Size by End Users
  5. 5.2.1 Global Conjugate Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Conjugate Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Conjugate Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by End Users
  9. 5.3.1 North America Conjugate Vaccine Sales Breakdown by End Users (2021-2026)
  10. 5.3.2 Europe Conjugate Vaccine Sales Breakdown by End Users (2021-2026)
  11. 5.3.3 Asia-Pacific Conjugate Vaccine Sales Breakdown by End Users (2021-2026)
  12. 5.3.4 South America Conjugate Vaccine Sales Breakdown by End Users (2021-2026)
  13. 5.3.5 Middle East and Africa Conjugate Vaccine Sales Breakdown by End Users (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Conjugate Vaccine Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Conjugate Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Conjugate Vaccine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Conjugate Vaccine Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Walvax Biotechnology
  26. 6.5.1 Walvax Biotechnology Company Information
  27. 6.5.2 Walvax Biotechnology Business Overview
  28. 6.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Walvax Biotechnology Conjugate Vaccine Product Portfolio
  30. 6.5.5 Walvax Biotechnology Recent Developments
  31. 6.6 Royal (Wuxi) Bio-Pharmaceutical
  32. 6.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
  33. 6.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
  34. 6.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio
  36. 6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
  37. 6.7 Bharat Biotech
  38. 6.7.1 Bharat Biotech Company Information
  39. 6.7.2 Bharat Biotech Business Overview
  40. 6.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bharat Biotech Conjugate Vaccine Product Portfolio
  42. 6.7.5 Bharat Biotech Recent Developments
  43. 6.8 Zhifei Biologic
  44. 6.8.1 Zhifei Biologic Company Information
  45. 6.8.2 Zhifei Biologic Business Overview
  46. 6.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zhifei Biologic Conjugate Vaccine Product Portfolio
  48. 6.8.5 Zhifei Biologic Recent Developments
7 North America by Country
  1. 7.1 North America Conjugate Vaccine Sales by Country
  2. 7.1.1 North America Conjugate Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Conjugate Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Conjugate Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Conjugate Vaccine Market Size by Country
  6. 7.2.1 North America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Conjugate Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Conjugate Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Conjugate Vaccine Sales by Country
  2. 8.1.1 Europe Conjugate Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Conjugate Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Conjugate Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Conjugate Vaccine Market Size by Country
  6. 8.2.1 Europe Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Conjugate Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Conjugate Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Conjugate Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Conjugate Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Conjugate Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Conjugate Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Conjugate Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Conjugate Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Conjugate Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Conjugate Vaccine Sales by Country
  2. 10.1.1 South America Conjugate Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Conjugate Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Conjugate Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Conjugate Vaccine Market Size by Country
  6. 10.2.1 South America Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Conjugate Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Conjugate Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Conjugate Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Conjugate Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Conjugate Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Conjugate Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Conjugate Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Conjugate Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Conjugate Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Conjugate Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Conjugate Vaccine Value Chain Analysis
  2. 12.1.1 Conjugate Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Conjugate Vaccine Production Mode & Process
  7. 12.2 Conjugate Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Conjugate Vaccine Distributors
  10. 12.2.3 Conjugate Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst